Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Refractive Surgery/Vision Correction > Topography-Guided LASIK Assessed
  • Refractive Surgery/Vision Correction

Topography-Guided LASIK Assessed

Ophthalmology 360
Article image

In patients with myopia and myopic astigmatism, topography-guided LASIK significantly increased the number of eyes that achieved 20/10 visual acuity between three and 12 months, according to a recent study.

Investigators looked at outcomes using the Contoura excimer laser. Among the results:

  • 20/10 corrected distance visual acuity (CDVA) was found in 1% of patients before surgery.
  • 20/10 or better uncorrected distance visual acuity (UDVA) was found in 7% of eyes at three months and 16% at 1 year. 
  • Patients with lower preoperative corneal astigmatism tended to fare best.

Durrie D, Stulting RD, Potvin R, Petznick A.  More eyes with 20/10 distance visual acuity at 12 months versus 3 months in a topography-guided excimer laser trial: possible contributing factors. [Published online ahead of print December 7, 2018]. J Cataract Refract Surg. doi: https://doi.org/10.1016/j.jcrs.2018.12.008 

Share

Related Content

  • Refractive Surgery/Vision Correction

VISUMAX 800 lenticule extraction linked to high satisfaction and spectacle independence

  • Refractive Surgery/Vision Correction

First-in-human study underway for non-invasive vision correction technology

  • Refractive Surgery/Vision Correction

Tips to successfully integrate EVO ICL into office-based surgery

Dr. Ling implanting EVO ICL
  • Refractive Surgery/Vision Correction

EVO ICL plays a strategic role in my refractive business model

  • Cornea and External Disease

Who is the ideal candidate for EVO ICL?

  • Cornea and External Disease

Impact of corneal size on refractive surgery outcomes highlighted in new research

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon